Soleil Securities Maintains a 'Buy' on Exxon Mobil (XOM); Cuts Estimates and Price Target
More News related to XOM
- ExxonMobil Chemical Increases Availability of Spectrasyn(TM) Polyalphaolefins
- ExxonMobil (XOM) Completes Rotterdam Aromatics Plant Expansion
- ExxonMobil Chemical Announces Expansion at Its Rotterdam Aromatics Plant
- A.M. Best Affirms Ratings of Ancon Insurance and Petroleum Casualty Group
- Crude Inventories Lower than Expected, Energy Shares Gain Ground (XOM, COP, CVX, MRO, USO, OIL)
More News related to Analyst Comments
- Citi Maintains 'Buy' Rating on Pinnacle West (PNW); Removes from 'Top Picks Live' List
- Baird Reiterates a 'Neutral' Rating on Genzyme (GENZ); Long-Term Implications Still Evolving
- Credit Suisse Maintains an 'Outperform' on Packaging Corp of America (PKG), Adds to Focus List
- Wedbush Adds Bed Bath & Beyond (BBBY) to 'Best Ideas' List, Removes PetSmart (PETM)
- Bernstein Maintains a 'Market Perform' on United Technologies (UTX); PT to $73
Soleil Securities maintains a 'Buy' on Exxon Mobil Corp. (NYSE: XOM), lowers price target from $90 to $87.
Soleil analyst says, "We are lowering our earnings estimates for ExxonMobil for 2009 (from $4.10/share to $4.00/share) and 2010 (from $6.60/share to $6.20/share) due primarily to the decline in NYMEX forward curve price assumptions for crude oil, natural gas and refining margins...We maintain our Buy rating, but are reducing our discounted free cash flow derived price target from $90/share to $87/share...Additionally, we re-iterate our Overweight rating on the integrated oil sector, which, based upon 2010E EV/EBITDA, is trading at a substantial discount (4.1x) to the average of the stocks in the XNG Index (6.5x) and OSX Index (7.2x), based upon First Call data."
To see more analyst ratings on XOM Click Here.
Exxon Mobil Corporation engages in the exploration, production, transportation, and sale of crude oil and natural gas.
Related Categories
Analyst CommentsStocks Mentioned
+0.89Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
